Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · IEX Real-Time Price · USD
34.67
-0.16 (-0.47%)
Mar 28, 2024, 11:19 AM EDT - Market open
IART Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1994 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1,542 | 1,558 | 1,542 | 1,372 | 1,518 | 1,472 | 1,188 | 992.08 | 882.73 | 796.72 | Upgrade
|
Revenue Growth (YoY) | -1.03% | 0.99% | 12.43% | -9.60% | 3.06% | 23.92% | 19.77% | 12.39% | 10.80% | 14.33% | Upgrade
|
Cost of Revenue | 656.84 | 587.36 | 597.81 | 520.83 | 564.68 | 571.5 | 435.51 | 349.09 | 326.54 | 302.95 | Upgrade
|
Gross Profit | 884.74 | 970.31 | 944.64 | 851.03 | 952.88 | 900.95 | 752.73 | 642.99 | 556.19 | 493.77 | Upgrade
|
Selling, General & Admin | 656.64 | 616.32 | 637.45 | 594.53 | 687.6 | 690.75 | 624.1 | 455.63 | 415.76 | 375.55 | Upgrade
|
Research & Development | 104.19 | 101.19 | 93.05 | 77.38 | 79.57 | 78.04 | 63.46 | 58.16 | 50.9 | 43.56 | Upgrade
|
Other Operating Expenses | 12.38 | 13.88 | 16.91 | 27.76 | 91.94 | 21.16 | 20.37 | 13.86 | 9.95 | 6.81 | Upgrade
|
Operating Expenses | 773.21 | 731.39 | 747.41 | 699.66 | 859.12 | 789.95 | 707.92 | 527.65 | 476.61 | 425.91 | Upgrade
|
Operating Income | 111.53 | 238.92 | 197.23 | 151.37 | 93.76 | 111 | 44.8 | 115.34 | 79.59 | 67.86 | Upgrade
|
Interest Expense / Income | 51.38 | 49.59 | 50.4 | 71.58 | 53.96 | 64.68 | 35.02 | 25.8 | 23.53 | 21.97 | Upgrade
|
Other Expense / Income | -20.92 | -24.57 | -67.84 | -13.73 | -20.3 | -11.09 | -1.6 | -0.87 | 5.75 | 2.62 | Upgrade
|
Pretax Income | 81.07 | 213.89 | 214.68 | 93.52 | 60.1 | 57.4 | 11.39 | 90.41 | 50.3 | 43.28 | Upgrade
|
Income Tax | 13.33 | 33.34 | 45.6 | -40.37 | 9.9 | -3.4 | -53.36 | 15.84 | 53.82 | 9.27 | Upgrade
|
Net Income | 67.74 | 180.55 | 169.08 | 133.89 | 50.2 | 60.8 | 64.74 | 74.56 | -3.52 | 34 | Upgrade
|
Net Income Growth | -62.48% | 6.79% | 26.28% | 166.71% | -17.43% | -6.09% | -13.17% | - | - | - | Upgrade
|
Shares Outstanding (Basic) | 80 | 83 | 85 | 85 | 86 | 83 | 77 | 74 | 69 | 65 | Upgrade
|
Shares Outstanding (Diluted) | 80 | 84 | 85 | 85 | 86 | 84 | 79 | 79 | 71 | 66 | Upgrade
|
Shares Change | -3.81% | -2.30% | 0.30% | -1.46% | 2.97% | 6.17% | -0.09% | 10.99% | 8.24% | 14.44% | Upgrade
|
EPS (Basic) | 0.85 | 2.18 | 2.00 | 1.58 | 0.59 | 0.73 | 0.84 | 1.00 | -0.05 | 0.52 | Upgrade
|
EPS (Diluted) | 0.84 | 2.16 | 1.98 | 1.57 | 0.58 | 0.72 | 0.82 | 0.94 | -0.05 | 0.52 | Upgrade
|
EPS Growth | -61.11% | 9.09% | 26.11% | 170.69% | -19.44% | -12.20% | -12.77% | - | - | - | Upgrade
|
Free Cash Flow | 73.09 | 233.27 | 264.41 | 168.6 | 161.93 | 122.36 | 71.33 | 69.39 | 72.88 | 45.23 | Upgrade
|
Free Cash Flow Per Share | 0.91 | 2.81 | 3.12 | 1.99 | 1.89 | 1.48 | 0.93 | 0.93 | 1.06 | 0.70 | Upgrade
|
Gross Margin | 57.39% | 62.29% | 61.24% | 62.03% | 62.79% | 61.19% | 63.35% | 64.81% | 63.01% | 61.98% | Upgrade
|
Operating Margin | 7.23% | 15.34% | 12.79% | 11.03% | 6.18% | 7.54% | 3.77% | 11.63% | 9.02% | 8.52% | Upgrade
|
Profit Margin | 4.39% | 11.59% | 10.96% | 9.76% | 3.31% | 4.13% | 5.45% | 7.52% | -0.40% | 4.27% | Upgrade
|
Free Cash Flow Margin | 4.74% | 14.98% | 17.14% | 12.29% | 10.67% | 8.31% | 6.00% | 6.99% | 8.26% | 5.68% | Upgrade
|
Effective Tax Rate | 16.44% | 15.59% | 21.24% | -43.17% | 16.48% | -5.92% | -468.67% | 17.52% | 107.00% | 21.42% | Upgrade
|
EBITDA | 258.15 | 384.6 | 388.74 | 284.09 | 228.58 | 232.82 | 135.35 | 188.87 | 132.7 | 111.68 | Upgrade
|
EBITDA Margin | 16.75% | 24.69% | 25.20% | 20.71% | 15.06% | 15.81% | 11.39% | 19.04% | 15.03% | 14.02% | Upgrade
|
Depreciation & Amortization | 125.7 | 121.12 | 123.67 | 118.99 | 114.52 | 110.73 | 88.95 | 72.67 | 58.86 | 46.43 | Upgrade
|
EBIT | 132.45 | 263.49 | 265.07 | 165.1 | 114.06 | 122.09 | 46.4 | 116.21 | 73.84 | 65.24 | Upgrade
|
EBIT Margin | 8.59% | 16.92% | 17.19% | 12.03% | 7.52% | 8.29% | 3.91% | 11.71% | 8.36% | 8.19% | Upgrade
|